Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma
Melanoma News
Publication date: Mar 06, 2019 This phase I trial studies the side effects and best dose of a modified virus called VSV-IFNbetaTYRP1 in treating patients with stage III-IV melanoma. The ... Read more